Brain Metastases in Non-Small Cell Lung Cancer
Author Information
Author(s): Jacot W, Quantin X, Boher J-M, Andre F, Moreau L, Gainet M, Depierre A, Quoix E, Chevalier T Le, Pujol J-L
Primary Institution: Hôpital Universitaire Arnaud de Villeneuve
Hypothesis
What are the prognostic factors affecting survival in patients with non-small cell lung cancer and brain metastases?
Conclusion
The study identified several prognostic factors that affect survival in patients with non-small cell lung cancer and brain metastases.
Supporting Evidence
- Patients with male gender, age over 63 years, and poor performance status had shorter survival.
- High serum neuron-specific enolase (NSE) levels were associated with poor outcomes.
- Neurological symptoms were identified as a specific determinant of poor prognosis in brain metastasis cases.
- Low serum sodium levels were linked to worse survival outcomes.
Takeaway
Doctors looked at 231 patients with lung cancer that spread to the brain to find out what affects how long they live.
Methodology
A multi-centre retrospective study analyzing clinical, radiological, and biological characteristics of patients using univariate and multivariate statistics.
Participant Demographics
Patients were from 4 French university institutions, with a focus on those with untreated non-small cell lung cancer and brain metastases.
Statistical Information
Confidence Interval
2.29 (1.26–4.16), 1.73 (1.15–2.62), 1.02 (1.003–1.043), 1.72 (1.11–2.68), 1.63 (1.05–2.54), 2.99 (1.17–7.62)
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website